UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062276
Receipt number R000071266
Scientific Title A multicenter prospective registry-based observational study of the clinical characteristics and treatment outcomes of thoracoabdominal complications associated with acute pancreatitis, including acute exacerbation of chronic pancreatitis, and surgical procedures
Date of disclosure of the study information 2026/07/20
Last modified on 2026/07/18 21:19:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter prospective registry study of the clinical features and treatment outcomes of thoracoabdominal complications associated with acute pancreatitis and surgical procedures

Acronym

WONDERFUL (WON anD pERipancreatic FlUid coLlection) study

Scientific Title

A multicenter prospective registry-based observational study of the clinical characteristics and treatment outcomes of thoracoabdominal complications associated with acute pancreatitis, including acute exacerbation of chronic pancreatitis, and surgical procedures

Scientific Title:Acronym

WONDERFUL (WON anD pERipancreatic FlUid coLlection) study

Region

Japan


Condition

Condition

Thoracoabdominal local complications associated with acute pancreatitis, including acute exacerbation of chronic pancreatitis, or surgical procedures. These include acute peripancreatic fluid collection (APFC), acute necrotic collection (ANC), pancreatic pseudocyst (PPC), and walled-off necrosis (WON) according to the revised Atlanta classification, as well as pleural effusion, ascites, and fluid collections or abscesses remote from the pancreas.

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery Emergency medicine
Intensive care medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To establish a large multicenter prospective registry cohort and comprehensively clarify the clinical characteristics and treatment outcomes of thoracoabdominal complications associated with acute pancreatitis and surgical procedures.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Clinical success

Key secondary outcomes

Treatment strategies, time to treatment, procedure time and treatment duration, number of procedures, technical success, need for step-up treatment, adverse events, length of hospital stay, medical costs, recurrence, reintervention, long-term outcomes and prognosis, and associations of patient factors, treatment factors, imaging findings, pancreatic duct findings, and microbiological findings with clinical outcomes.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients with thoracoabdominal local complications associated with acute pancreatitis, including acute exacerbation of chronic pancreatitis, or surgical procedures, who receive routine clinical care.
2. Patients aged 18 years or older, irrespective of sex.
3. Outpatients or inpatients managed by the participating departments, including co-managed cases.
Patients referred after resolution of the acute inflammatory phase with persistent local complications are also eligible.

Key exclusion criteria

Patients considered inappropriate for inclusion by the treating physician.

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name Naminatsu
Middle name
Last name Takahara

Organization

Graduate School of Medicine, The University of Tokyo

Division name

Department of Gastroenterology

Zip code

113-8655

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

TEL

03-3815-5411

Email

takaharan-int@h.u-tokyo.ac.jp


Public contact

Name of contact person

1st name Tomotaka
Middle name
Last name Saito

Organization

Graduate School of Medicine, The University of Tokyo

Division name

Department of Gastroenterology

Zip code

113-8655

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

TEL

03-3815-5411

Homepage URL


Email

tomsaito-gi@umin.ac.j


Sponsor or person

Institute

The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Departmental operating funds of the Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Graduate School of Medicine, The University of Tokyo, Office for Human Research Studies

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan

Tel

03-3815-5411

Email

ethics@m.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

1. 東京大学大学院医学系研究科・消化器内科
2. 富山大学学術研究部医学系内科学第三講座・消化器内科
3. 順天堂大学医学部附属順天堂医院・消化器内科
4. 岐阜大学医学部附属病院・第一内科
5. 神戸大学・消化器内科
6. 近畿大学病院・消化器内科
7. 兵庫医科大学・肝胆膵内科
8. 岐阜県総合医療センター・消化器内科
9. 岐阜市民病院・消化器内科
10. 埼玉医科大学総合医療センター・消化器・肝臓内科


Other administrative information

Date of disclosure of the study information

2026 Year 07 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 01 Month 30 Day

Date of IRB

2024 Year 01 Month 30 Day

Anticipated trial start date

2024 Year 01 Month 30 Day

Last follow-up date

2028 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a multicenter prospective registry-based observational study conducted by the WONDERFUL study group for thoracoabdominal complications associated with acute pancreatitis and surgical procedures. Machine-learning and deep-learning analyses using clinical and imaging data are also planned.


Management information

Registered date

2026 Year 07 Month 18 Day

Last modified on

2026 Year 07 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071266